SEC Form 4 · accession 0001246360-17-001214
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert S. Brown
Officer — President, NxStage Kidney Care
Period of report
Mar 3, 2017
Accepted (ET)
Mar 6, 2017 · 6:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 3, 2017 | M | 9,747 | $0.00 | A | 27,062 | D | |
| Common Stock | Mar 3, 2017 | F | 4,586 | $28.31 | D | 22,476 | D | |
| Common Stock | Mar 6, 2017 | S | 6,390 | $28.01 | D | 16,086 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Unit | $0.00 | Mar 3, 2017 | M | 9,747 | D | Mar 3, 2015 | Mar 3, 2017 | Common Stock | 9,747 | 0 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2016.